ArticleWorld journal of gastroenterology2025
Tetrahydroxylated bile acids prevents malignant progression of Barret esophagus
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBarrett esophagus (BE), a metaplastic adaptive process to gastrointestinal reflux, is associated with a higher risk of developing esophageal adenocarcinoma. However, the factors and mechanism that drive the malignant progression of BE is not well understood.
aimTo investigate the role of bile acids, a component of the reflux fluid, in the malignant progression of BE.
methodsUsing engineered green fluorescent protein- labeled adult tissue-resident stem cells isolated from BE clinical biopsies (BE-ASCs) as the target, we studied the effect of hydrophobic deoxycholic acid (DCA) and hydrophilic tetrahydroxylated bile acids (THBA) on cell viability by fluorescence intensity analysis, mucin production by dark density measurement, tissue structure by pathology analysis, expression of different pro-inflammatory factors gene by quantitative polymerase chain reaction and proteins by Western blot.
resultsWe found that hydrophobic DCA has cytotoxic and proinflammatory effects through activation of interleukin-1β (IL-1β)-nuclear factor kappa-B (NF-κB) inflammatory pathway on BE-ASCs. This action results in impaired cell viability, tissue intactness, reduced mucin production, and increased transition to disorganized atypical cells without intestinal features. In contrast, co-culture with hydrophilic THBA inhibited the IL-1β-NF-κB inflammatory pathway with maintenance of mature intestinal type cellular and histomorphology.
conclusionOur data indicates that the hydrophilic bile acid THBA can counteract the cytotoxic and proinflammatory effect of hydrophobic DCA and prevent the malignant progression of BE by inhibiting the IL-1β-NF-κB pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.